![Sung Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sung Lee
Director of Finance/CFO at
CYTOKINETICS, INCORPORATED
Net worth: 5 M $ as of 29/04/2026
Profile
Mr. Sung H.
Lee is a Lead Independent Director at Tango Therapeutics, Inc. and a CFO, Principal Accounting Officer & EVP at Cytokinetics, Inc. He is on the Board of Directors at Tango Therapeutics, Inc. Mr. Lee was previously employed as a Chief Financial Officer & Executive Vice President by Vir Biotechnology, Inc., a Chief Financial Officer by MorphoSys AG, a Chief Financial Officer & Executive Vice President by Sangamo Therapeutics, Inc., and a Vice President-Investor Relations by Gilead Sciences, Inc. He received his undergraduate degree from the University of California, Irvine and a graduate degree from the University of Southern California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/05/2026 | 63,221 ( 0.05% ) | 4 M $ | 29/04/2026 | |
| 28/04/2026 | 22,300 ( 0.02% ) | 482 126 $ | 29/04/2026 |
Sung Lee active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director of Finance/CFO | 07/05/2024 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | 04/01/2026 |
Former positions of Sung Lee
| Companies | Position | End |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director of Finance/CFO | 02/05/2024 |
| MORPHOSYS AG | Director of Finance/CFO | 16/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 31/01/2021 |
| GILEAD SCIENCES, INC. | Investor Relations Contact | 30/10/2019 |
Training of Sung Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
- Stock Market
- Insiders
- Sung Lee
